---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-014299"
form_type: "8-K"
ticker: "XNCR"
cik: "0001326732"
company_name: "Xencor Inc"
filed_at: "2022-09-09T23:59:59+00:00"
generated_at: "2026-06-23T11:48:49.707657+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Xencor appoints Nancy Valente to board; Yujiro Hata resigns

## Summary
- Nancy Valente, M.D., appointed to Board on Sept 8, 2022; she brings 20+ yrs pharma experience.
- Yujiro Hata's resignation accepted by Board on Sept 8, 2022; he served since 2015.
- Valente receives initial option grant valued at $550k (Black-Scholes) plus $50k annual cash retainer.
- Valente most recently SVP at Genentech/Roche, led global oncology/hematology product development.

## SEC filing metadata
- accession: 0001558370-22-014299
- form_type: 8-K
- ticker: XNCR
- cik: 0001326732
- company_name: Xencor Inc
- filed_at: 2022-09-09T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326732/000155837022014299/0001558370-22-014299-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326732/000155837022014299/xncr-20220909x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-014299
- JSON: https://secwatch.observer/filing/0001558370-22-014299.json
- Plain text: https://secwatch.observer/filing/0001558370-22-014299.txt

## Key facts
- Executive change
  Yujiro S. Hata resigned as Director at Xencor Inc.
  - Action: resigned
  - Role: Director
  source text: On June 23, 2022, Yujiro S. Hata tendered his offer of resignation from the Board of Directors (the “Board”) of Xencor, Inc. (the “Company”), subject to the Board’s acceptance of his resignation. On September 8, 2022, the Board accepted Mr. Hata’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326732/000155837022014299/0001558370-22-014299-index.htm
- Executive change
  Nancy Valente was appointed as Director at Xencor Inc.
  - Action: appointed
  - Role: Director
  source text: On September 8, 2022, Nancy Valente was appointed to the Board of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326732/000155837022014299/0001558370-22-014299-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.